Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma

References

• LouisDN, OhgakiH, WiestlerOD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-417618441
   PubMed Web of Science ®Google Scholar
• Peñaranda-FajardoNM, MeijerC, LiangY, et al. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation. Cell Death Dis. 2019;10(10):690. doi:10.1038/s41419-019-1934-131534165
   PubMed Web of Science ®Google Scholar
• UngerMM, SpiegelJ, DillmannKU, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. doi:10.1016/j.parkreldis.2016.08.01927591074
   PubMed Web of Science ®Google Scholar
• NieP, LiZ, WangY, et al. Gut microbiome interventions in human health and diseases. Med Res Rev. 2019;39(6):2286–2313. doi:10.1002/med.2158430994937
   PubMed Web of Science ®Google Scholar
• ScheperjansF, AhoV, PereiraPA, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30(3):350–358. doi:10.1002/mds.2606925476529
   PubMed Web of Science ®Google Scholar
• VogtNM, KerbyRL, Dill-McFarlandKA, et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017;7(1):13537. doi:10.1038/s41598-017-13601-y29051531
   PubMed Web of Science ®Google Scholar
• MulakA, BonazB. Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol. 2015;21(37):10609–10620. doi:10.3748/wjg.v21.i37.1060926457021
   PubMed Web of Science ®Google Scholar
• D’AlessandroG, AntonangeliF, MarroccoF, et al. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice. Eur J Immunol. 2020;50(5):705–711. doi:10.1002/eji.20194835432034922
   PubMed Web of Science ®Google Scholar
• Mehrian-ShaiR, ReichardtJKV, HarrisCC, et al. The gut-brain axis, paving the way to brain cancer. Trends Cancer. 2019;5(4):200–207. doi:10.1016/j.trecan.2019.02.00830961828
   PubMed Web of Science ®Google Scholar
• MargisonGP, Santibáñez KorefMF, PoveyAC. Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis. 2002;17(6):483–487. doi:10.1093/mutage/17.6.48312435845
   PubMed Web of Science ®Google Scholar
• StuppR, MasonWP, van den BentMJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. doi:10.1056/NEJMoa04333015758009
   PubMed Web of Science ®Google Scholar
• ViaudS, SaccheriF, MignotG, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–976. doi:10.1126/science.124053724264990
   PubMed Web of Science ®Google Scholar
• IidaN, DzutsevA, StewartCA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967–970. doi:10.1126/science.124052724264989
   PubMed Web of Science ®Google Scholar
• DaillèreR, VétizouM, WaldschmittN, et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 2016;45(4):931–943. doi:10.1016/j.immuni.2016.09.00927717798
   PubMed Web of Science ®Google Scholar
• LiF, WangP, ChenZ, et al. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neurosci Lett. 2019;707:134297. doi:10.1016/j.neulet.2019.13429731200089
   PubMed Web of Science ®Google Scholar
• PengA, QiuX, LaiW, et al. Altered composition of the gut microbiome in patients with drug-resistant epilepsy. Epilepsy Res. 2018;147:102–107. doi:10.1016/j.eplepsyres.2018.09.01330291996
   PubMed Web of Science ®Google Scholar
• HuangC, LiY, FengX, et al. Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy. Front Pediatr. 2019;7:394. doi:10.3389/fped.2019.0039431646147
   PubMed Web of Science ®Google Scholar
• VandeputteD, KathagenG, D’HoeK, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507–511. doi:10.1038/nature2446029143816
   PubMed Web of Science ®Google Scholar
• PropsR, KerckhofFM, RubbensP, et al. Absolute quantification of microbial taxon abundances. Isme j. 2017;11(2):584–587. doi:10.1038/ismej.2016.11727612291
   PubMed Web of Science ®Google Scholar
• SmetsW, LeffJW, BradfordMA, et al. A method for simultaneous measurement of soil bacterial abundances and community composition via 16S rRNA gene sequencing. Soil Biol Biochem. 2016;96:145–151.
   Web of Science ®Google Scholar
• FeldmanLA, FabreMS, GrassoC, et al. Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas. PLoS One. 2017;12(9):e0184250. doi:10.1371/journal.pone.018425028873460
   PubMed Web of Science ®Google Scholar
• RoundJL, MazmanianSK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323. doi:10.1038/nri251519343057
   PubMed Web of Science ®Google Scholar
• WuS, LiuY, DuanY, et al. Intestinal toxicity of deoxynivalenol is limited by supplementation with Lactobacillus plantarum JM113 and consequentially altered gut microbiota in broiler chickens. J Anim Sci Biotechnol. 2018;9:74. doi:10.1186/s40104-018-0286-530338065
   PubMed Web of Science ®Google Scholar
• SivamaruthiBS, KesikaP, ChaiyasutC. The role of probiotics in colorectal cancer management. Evid Based Complement Alternat Med. 2020;2020:3535982. doi:10.1155/2020/353598232148539
   PubMed Web of Science ®Google Scholar
• LokeMF, ChuaEG, GanHM, et al. Metabolomics and 16S rRNA sequencing of human colorectal cancers and adjacent mucosa. PLoS One. 2018;13(12):e0208584. doi:10.1371/journal.pone.020858430576312
   PubMed Web of Science ®Google Scholar
• WangZ, WangH, KangZ, et al. Antioxidant and anti-tumour activity of triterpenoid compounds isolated from Morchella mycelium. Arch Microbiol. 2020;202(7):1677–1685. doi:10.1007/s00203-020-01876-132285166
   PubMed Web of Science ®Google Scholar
• LiM, van EschB, WagenaarGTM, et al. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018;831:52–59. doi:10.1016/j.ejphar.2018.05.00329750914
   PubMed Web of Science ®Google Scholar
• FernándezJ, Redondo-BlancoS, Gutiérrez-Del-RíoI, et al. Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: a review. J Funct Foods. 2016;25:511–522.
   Web of Science ®Google Scholar
• ParkE, GimJ, KimDK, et al. Protective effects of alpha-lipoic acid on glutamate-induced cytotoxicity in C6 glioma cells. Biol Pharm Bull. 2019;42(1):94–102. doi:10.1248/bpb.b18-0060330606992
   PubMed Web of Science ®Google Scholar
• RoutyB, Le ChatelierE, DerosaL, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–97. doi:10.1126/science.aan370629097494
   PubMed Web of Science ®Google Scholar
• CaniPD, de VosWM. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. doi:10.3389/fmicb.2017.0176529018410
   PubMed Web of Science ®Google Scholar
• ConsonniA, CordiglieriC, RinaldiE, et al. Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats. Oncotarget. 2018;9(32):22269–22287. doi:10.18632/oncotarget.2517029854277
   PubMedGoogle Scholar
• RossiM, AmarettiA, RaimondiS. Folate production by probiotic bacteria. Nutrients. 2011;3(1):118–134. doi:10.3390/nu301011822254078
   PubMed Web of Science ®Google Scholar
• SanchezH, HossainMB, LeraL, et al. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes p16, MLH1, and MGMT in elderly Chileans. Clin Epigenetics. 2017;9:74. doi:10.1186/s13148-017-0374-y28748002
   PubMed Web of Science ®Google Scholar